Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma
Masayuki Yokoyama(Jikei University School of Medicine), Atsushi Iwama(Chiba University)
Cited by 47
Related Papers
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
|Blood|2012|189
Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies
|The Journal of Experimental Medicine|2017|60
Antigenicity Extension: A Novel Concept Explained by the Immunogenicity of PEG
|ACS Bio & Med Chem Au|2024|10